A Comparative Study between CRP/Albumin Ratio and Serum Procalcitonin as A Prognostic Marker in Sepsis
Authors/Creators
- 1. MD, Department of Medicine, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan deemed to be University, Bhubaneswar, India
- 2. MD, Department of Medicine, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan deemed to be University, Bhubaneswar, India.
- 3. Ph.D., Department of Gastroenterology, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan deemed to be University, Bhubaneswar, India.
- 4. MD, DM, Department of Gastroenterology, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan deemed to be University, Bhubaneswar, India
Description
Backgrounds: One of the most prevalent causes of death among hospitalized patients in the critical care unit is sepsis (ICU). Because of the various co-morbidities and underlying disorders that these people have, diagnosing them is very difficult. A combination of hematological, biochemical, and microbiological tests can be used to identify sepsis. PCT and CRP levels are commonly considered valid indicators of the degree of systemic inflammation. The ratio of CRP to albumin is increasingly used as a biomarker for both systemic inflammation and nutritional status. The current study aimed to see if the CRP/albumin ratio, combined with procalcitonin, could be used to predict sepsis. Methods: This was a prospective cross-sectional study carried out with 150 patients. Baseline characteristics, biochemical investigations, and serum CRP/albumin ratios were done. The quantitative variables were expressed as mean and standard deviation compared by ANOVA followed by Bonferroni’s correction. A p-value of <0.05 was considered significant. Results: Serum procalcitonin levels were significantly higher on day-1 in non-survivors compared to survivors (P<0.0001). CRP/albumin ratio was substantially higher on day-1, day-3, and the day of discharge in non-survivors compared to survivors (P<0.0001). Conclusion: Despite the use of optimal treatment and an improved approach, the death rate in sepsis has been proven to be high (56.2 percent). Patients with increased procalcitonin and CRP/albumin ratio at admission can be better classified and identified as having a higher risk of adverse outcomes.
Abstract (English)
Backgrounds: One of the most prevalent causes of death among hospitalized patients in the critical care unit is sepsis (ICU). Because of the various co-morbidities and underlying disorders that these people have, diagnosing them is very difficult. A combination of hematological, biochemical, and microbiological tests can be used to identify sepsis. PCT and CRP levels are commonly considered valid indicators of the degree of systemic inflammation. The ratio of CRP to albumin is increasingly used as a biomarker for both systemic inflammation and nutritional status. The current study aimed to see if the CRP/albumin ratio, combined with procalcitonin, could be used to predict sepsis. Methods: This was a prospective cross-sectional study carried out with 150 patients. Baseline characteristics, biochemical investigations, and serum CRP/albumin ratios were done. The quantitative variables were expressed as mean and standard deviation compared by ANOVA followed by Bonferroni’s correction. A p-value of <0.05 was considered significant. Results: Serum procalcitonin levels were significantly higher on day-1 in non-survivors compared to survivors (P<0.0001). CRP/albumin ratio was substantially higher on day-1, day-3, and the day of discharge in non-survivors compared to survivors (P<0.0001). Conclusion: Despite the use of optimal treatment and an improved approach, the death rate in sepsis has been proven to be high (56.2 percent). Patients with increased procalcitonin and CRP/albumin ratio at admission can be better classified and identified as having a higher risk of adverse outcomes.
Files
IJPCR,Vol15,Issue12,Article116.pdf
Files
(433.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:48ec3e79431e706f9b49d9c53caf8c18
|
433.2 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-11-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue12,Article116.pdf
- Development Status
- Active
References
- 1. Novosad SA, Sapiano MR, Grigg C, Lake J, Robyn M, Dumyati G, Felsen C, Blog D, Dufort E, Zansky S, Wiedeman K. Vital signs: epidemiology of sepsis: prevalence of health care factors and opportunities for prevention. Morb Mortal Wkly. 2016; 65(33):864-69. 2. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323-329. 3. Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009: 37(5):1649. 4. Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013; 50:23-36. 5. Nargis W, Ibrahim MD, Ahamed BU. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014; 4:195. 6. Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016; 9:229-55. 7. Kim MH, Ahn JY, Song JE, Choi H, Ann HW, Kim JK, Kim JH, Jeon YD, Kim SB, Jeong SJ, Ku NSThe C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PloS one. 2015; 10: e0132109. 8. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34:1589-96. 9. Chatterjee S, Bhattacharya M, Todi SK. Epidemiology of Adult-population Sepsis in India: A Single Center 5 Year Experience. Indian J Crit Care Med. 2017; 21:573–77. 10. Jain S, Sinha S, Sharma SK, Samantaray JC, Aggrawal P, Vikram NK, Biswas A, Sood S, Goel M, Das M, Vishnubhatla S. Procalcitonin as a prognostic marker for sepsis: a prospective observational study. BMC Res Notes.2014;7:458.http://www.biomedcentral.c om/1756-0500/7/458. 11. Eachempati SR, Hydo L, Barie PS. Genderbased differences in outcome in patients with sepsis. Arch Surg. 1999; 134:1342-47. 12. Neveu H, Kleinknecht D, Brivet F, Loirat PH, Landais P. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant. 1996; 11:293-99. 13. Levi M, Schultz M, van der Poll T. Sepsis and thrombosis. Semin Thromb Hemost. 2013; 39:559–66. 14. Liu J, Bai C, Li B, Shan A, Shi F, Yao C, Zhang Y, Wang J, Chen W, Xie M, Deng D. Mortality prediction using a novel combination of biomarkers in the first day of sepsis in intensive care units. Sci Rep. 2021; 11:1275. 15. Meng FS, Su L, Tang YQ, Wen Q, Liu YS, Liu ZF. Serum procalcitonin at the time of admission to the ICU as a predictor of shortterm mortality. Clin Biochem. 2009; 42:1025- 31. 16. Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y. Differential diagnostic value of procalcitonin in surgical and medical patientswith septic shock. Crit Care Med. 2006; 34:102-07. 17. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008; 36:941-52. 18. Claeys R, Vinken S, Spapen H, ver Elst K, Huyghens L, Gorus FK. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med. 2002; 30:757–62. 19. Xie Q, Zhou Y, Xu Z, Yang Y, Kuang D, You H, Ma S, Hao C, Gu Y, Lin S, Ding F. The ratio of CRP to prealbumin levels predicts mortality in patients with hospital-acquired acute kidney injury. BMC Nephrol. 2011; 12:30. 20. Ranzani OT, Zampieri FG, Forte DN. Creactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One. 2013; 8: e59321.